CB2 is normally up-regulated following pro-inflammatory and nociceptive stimuli, and in human brain tissues affected by Alzheimer's disease (AD), multiple sclerosis (MS) and amyotrophic lateral sclerosis (ALS). These CB2 knockout mice (CB2-, CB2R- or Cnr2-) may be useful for studying these diseases, pain management and drug/antibody therapeutics.Read More +
Cannabinoid receptor 2 (CB2 or CB2R) is normally expressed in cells of the haematopoietic lineage, central nervous system and bone. In immune cells, CB2 is expressed on leukocytes and localized in intracellular membranous structures. Endogenous expression is up-regulated by pro-inflammatory and nociceptive stimuli. CB2 activation reduces expression of adhesion molecules in brain endothelium, decreasing leukocyte engagement and recruitment.
In these CB2 knockout mice (CB2-/-, CB2R-/-, Cnr2-/- or Cnr2tm1Dgen), CB2 agonists have no effect on minimizing leukocyte-endothelial cell interaction. After treatment with lipopolysaccharide (LPS), CB2 null mice fail to show complete resolution of inflammation compared to wild type controls. An increase in leukocyte adhesion is seen when Cnr2-/- leukocytes are transferred into wildtype recipient mice.
This CB2 knockout mutant was created and characterized by Deltagen, Inc. View phenotypic data developed by Deltagen.
J20 transgenic amyloid mice express the K670N/M671L/V717F mutant form of amyloid precursor protein under control of the human platelet-derived growth factor β polypeptide promoter (Stock No. 006293). Hemizygous J20 mice are a Familial Alzheimer's Disease model with progressive amyloid deposition as they age (significant reactive microgliosis by 8 months of age). C57BL/6 mice homozygous for Cnr2tm1Dgen and also harboring the J20 transgene (J20 CNR2/-/) exhibit increased amyloid pathology (increased soluble Aβ42, plaque deposition and plaque associated microglia), but altered tau processing (suppressed total tau), when compared to J20 mice alone.
Of note, another published CB2 knockout allele (Cnr2tm1Zim) has been used to show CB2-deficient macrophages are resistant to the inhibitory effects of δ-9 tetrahydrocannabinol (THC) and CB2 knockout mice have increased severity in experimental autoimmune encephalitis. Homozygous Cnr2tm1Zim mice also harboring the R6/2 transgene (encoding human mutant Huntington exon 1) have increased microglial activation and exacerbated Huntington disease progression/excitotoxicity compared to R6/2 mice alone.
The CB2 knockout allele (CB2-, CB2R-, Cnr2- or Cnr2tm1Dgen) was created by Deltagen. Specifically, the "Neo555T" construct was electroporated into 129P2/OlaHsd-derived E14 embryonic stem (ES) cells. Targeted mutant cell line 655 had homologous recombination of the "Neo555T" construct resulting in a 334 bp deletion in the coding exon of cannabinoid receptor 2 [macrophage] locus (CB2; Cnr2) on chromosome 2. The donating investigator reported the Cnr2- mice were backcrossed at least five generations to C57BL/6 mice (see SNP note below) prior to sending to The Jackson Laboratory Repository.
A 32 SNP (single nucleotide polymorphism) panel analysis, with 27 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. While the 27 markers throughout the genome suggested a C57BL/6 genetic background, 2 of 5 markers that determine C57BL/6J from C57BL/6N were found to be segregating. These data suggest the mice sent to The Jackson Laboratory Repository were on a mixed C57BL/6J ; C57BL/6N genetic background.
|Allele Name||targeted mutation 1, Deltagen|
|Allele Type||Targeted (Null/Knockout)|
|Gene Symbol and Name||Cnr2, cannabinoid receptor 2 (macrophage)|
|Gene Synonym(s)||CB-2; CB2; CB2-R; CB2C; CNR2C; CX5; cannabinoid receptor 2 (spleen)|
|Strain of Origin||129P2/OlaHsd|
|Molecular Note||This gene was disrupted by homologous recombination. Normally, RNA transcripts are detectable in lung, liver, thymus, spleen, lymph nodes, bone marrow, skin and testis.|
When maintaining a live colony, heterozygous or homozygous mice may be bred together.
When using the CB2R KO mouse strain in a publication, please cite the originating article(s) and include JAX stock #005786 in your Materials and Methods section.
|Heterozygous or Wild-type for Cnr2<tm1Dgen>|
We will fulfill your order by providing at least two carriers for each strain ordered. The total number, sex, and genotypes provided will vary, although typically 8 or more animals are provided. Please check genotypes which will be recovered. While the genotypes of all animals produced will be communicated to you prior to scheduling shipment, the genotypes of animals provided may not reflect the mating scheme and genotypes described in the strain description. Animals are typically ready to ship in 11-14 weeks. If a second recovery is required to produce the minimum number of animals, then delivery time would increase to approximately 25 weeks. If we fail to produce animals of the correct genotype, you will not be charged. We cannot guarantee the reproductive success of mice shipped to your facility. If the mice are lost after the first three days (post-arrival) or do not produce progeny at your facility, a new order and fee will be necessary.
Cryorecovery to establish a Dedicated Supply for greater quantities of mice. Mice recovered can be used to establish a dedicated colony to contractually supply you mice according to your requirements. Price by quotation.
"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.
MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.
Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.